Federated Hermes, Inc. Praxis Precision Medicines, Inc. Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.83 - $1.18 $18,323 - $26,050	-22,077 Reduced 5.69%	365,690 $420,000
Q1 2023 May 08, 2023	BUY	$0.8 - $4.98 $15,469 - $96,298	19,337 Added 5.25%	387,767 $314,000
Q4 2022 Feb 13, 2023	BUY	$1.88 - $36.45 $535,711 - $10.4 Million	284,953 Added 341.36%	368,430 $876,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $37.95 $208,692 - $3.17 Million	83,477 New	83,477 $189,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.